SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001746473-21-000019
Filing Date
2021-08-09
Accepted
2021-08-09 16:21:46
Documents
77
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plrx-20210630.htm   iXBRL 10-Q 1738681
2 EX-31.1 a2q2021-ex311.htm EX-31.1 9712
3 EX-31.2 a2q2021-ex312.htm EX-31.2 9680
4 EX-32.1 a2q2021-ex321.htm EX-32.1 7364
  Complete submission text file 0001746473-21-000019.txt   6725455

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plrx-20210630.xsd EX-101.SCH 53295
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plrx-20210630_cal.xml EX-101.CAL 45330
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plrx-20210630_def.xml EX-101.DEF 267248
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plrx-20210630_lab.xml EX-101.LAB 591508
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plrx-20210630_pre.xml EX-101.PRE 407801
10 EXTRACTED XBRL INSTANCE DOCUMENT plrx-20210630_htm.xml XML 919053
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39303 | Film No.: 211156793
SIC: 2834 Pharmaceutical Preparations